This page includes the latest FDA filings for Acelrx Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | ACRX | DUNS 789244774 |
Device Company | Device | Date |
|---|---|---|
| AcelRx Pharmaceuticals, Inc., Patheon Pharmaceuticals Inc. | Prescription Medication | 2023-12-22 |
| AcelRx Pharmaceuticals, Inc., Patheon Pharmaceuticals Inc. | Prescription Medication | 2019-10-19 |
| AcelRx Pharmaceuticals, Inc | Dsuvia | 2018-11-02 |
| NCAGE Code | 5ZVQ4 | ACELRX PHARMACEUTICALS, INC. |
| CAGE Code | 5ZVQ4 | ACELRX PHARMACEUTICALS, INC. |
| S.A.M. Registration | 5ZVQ4 [789244774] | ACELRX PHARMACEUTICALS, INC. |
| SEC | 0001427925 | ACELRX PHARMACEUTICALS INC of DELAWARE |